omeprazole has been researched along with Lung Diseases in 8 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Lung Diseases: Pathological processes involving any part of the LUNG.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Episodes of respiratory distress with chest retraction and wheezing, sometimes associated with facial edema, were noted after administering the proton pump inhibitors omeprazole and esomeprazole in an infant with gastroesophageal reflux." | 3.74 | Severe systemic adverse reaction to proton pump inhibitors in an infant. ( Baldassarre, E; Bianchetti, MG; Ferrarini, A; Sagaon, MM, 2007) |
| "However, the case that GERD is the cause of these symptoms is difficult to make because neither endoscopy nor prolonged reflux monitoring has shown consistent evidence of either esophageal injury or abnormal reflux frequency." | 2.43 | State of the art: extraesophageal manifestations of gastroesophageal reflux disease. ( Katz, PO, 2005) |
| "No further recurrence with 20 mg omeprazole was found later than six months." | 1.28 | Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis. ( Arnold, R; Koop, H, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deregnaucourt, D | 1 |
| Buche, S | 1 |
| Coopman, S | 1 |
| Basraoui, D | 1 |
| Turck, D | 1 |
| Delaporte, E | 1 |
| Denier, C | 1 |
| Bouteredjiret, T | 1 |
| Dreyfus, M | 1 |
| Lacroix, C | 1 |
| Adams, D | 1 |
| Sawabata, N | 1 |
| Maeda, H | 1 |
| Takeda, S | 1 |
| Inoue, M | 1 |
| Koma, M | 1 |
| Tokunaga, T | 1 |
| Matsuda, H | 1 |
| Katz, PO | 2 |
| Baldassarre, E | 1 |
| Sagaon, MM | 1 |
| Ferrarini, A | 1 |
| Bianchetti, MG | 1 |
| Israel, DM | 1 |
| Hassall, E | 1 |
| Koop, H | 1 |
| Arnold, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Application of Vagus Nerve Preservation in Minimally Invasive Surgery for Early Lung Cancer[NCT04125979] | 120 participants (Anticipated) | Interventional | 2019-01-01 | Recruiting | |||
| Prospective Randomized Controlled Study on the Effects of Vagus Nerve Pulmonary Branch Preservation During Video-assisted Thoracic Surgery Lobectomy in Non-small Cell Lung Cancer: Can it Decrease Postoperative Cough and Pulmonary Complications[NCT04923412] | 214 participants (Anticipated) | Interventional | 2021-07-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for omeprazole and Lung Diseases
| Article | Year |
|---|---|
State of the art: extraesophageal manifestations of gastroesophageal reflux disease.
Topics: Clinical Trials as Topic; Enzyme Inhibitors; Gastroesophageal Reflux; Humans; Lung Diseases; Omepraz | 2005 |
Gastroesophageal reflux disease and extraesophageal disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Asthma; Benzimidazoles; Esophageal pH Mo | 2005 |
Omerprazole and other proton pump inhibitors: pharmacology, efficacy, and safety, with special reference to use in children.
Topics: Barrett Esophagus; Child; Enzyme Inhibitors; Esophagitis; Humans; Lung Diseases; Omeprazole; Peptic | 1998 |
5 other studies available for omeprazole and Lung Diseases
| Article | Year |
|---|---|
[Pyoderma gangrenosum with lung involvement treated with infliximab].
Topics: Adolescent; Adrenal Cortex Hormones; Analgesics; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerat | 2013 |
Late and fatal deterioration of an intracerebral hemorrhage attributable to the onset of a high titer of acquired factor V inhibitor.
Topics: Aged; Anti-Ulcer Agents; Antihypertensive Agents; Cerebral Hemorrhage; Factor V; Factor V Deficiency | 2008 |
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Carcinoma, Non-Small-Cell Lung; Chronic D | 2005 |
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Carcinoma, Non-Small-Cell Lung; Chronic D | 2005 |
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Carcinoma, Non-Small-Cell Lung; Chronic D | 2005 |
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Carcinoma, Non-Small-Cell Lung; Chronic D | 2005 |
Severe systemic adverse reaction to proton pump inhibitors in an infant.
Topics: Enzyme Inhibitors; Esomeprazole; Female; Gastroesophageal Reflux; Humans; Infant; Lung Diseases; Ome | 2007 |
Long-term maintenance treatment of reflux esophagitis with omeprazole. Prospective study in patients with H2-blocker-resistant esophagitis.
Topics: Adult; Aged; Body Weight; Drug Administration Schedule; Drug Resistance; Esophagitis, Peptic; Esopha | 1991 |